Literature DB >> 12668917

Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations.

Peter K Rogan1, Stan Svojanovsky, J Steven Leeder.   

Abstract

Several mutations are known or suspected to affect mRNA splicing of CYP2C19, CYP2D6 and CYP3A5 genes; however, little experimental evidence exists to support these conclusions. The present study applies mathematical models that measure changes in information content of splice sites in these genes to demonstrate the relationship between the predicted phenotypes of these variants to the corresponding genotypes. Based on information analysis, the CYP2C19*2 variant activates a new cryptic site 40 nucleotides downstream of the natural splice site. CYP2C19*7 abolishes splicing at the exon 5 donor site. The CYP2D6*4 allele similarly inactivates splicing at the acceptor site of exon 4 and activates a new cryptic site one nucleotide downstream of the natural acceptor. CYP2D6*11 inactivates the acceptor site of exon 2. The CYP3A5*3 allele activates a new cryptic site 236 nucleotides upstream of the exon 4 natural acceptor site. CYP3A5*5 inactivates the exon 5 donor site and CYP3A5*6 strengthens a site upstream of the natural donor site, resulting in skipping of exon 7. Other previously described missense and nonsense mutations at terminal codons of exons in these genes affected splicing. CYP2D6*8 and CYP2D6*14 both decrease the strength of the exon 3 donor site, producing transcripts lacking this exon. The results of information analysis are consistent with the poor metabolizer phenotypes observed in patients with these mutations, and illustrate the potential value of these mathematical models to quantitatively evaluate the functional consequences of new mutations suspected of altering mRNA splicing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668917     DOI: 10.1097/00008571-200304000-00005

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  19 in total

1.  Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans.

Authors:  A Gaedigk; A Bhathena; L Ndjountché; R E Pearce; S M Abdel-Rahman; S W Alander; L DiAnne Bradford; P K Rogan; J Steven Leeder
Journal:  Pharmacogenomics J       Date:  2005       Impact factor: 3.550

Review 2.  Normal and abnormal mechanisms of gene splicing and relevance to inherited skin diseases.

Authors:  Vesarat Wessagowit; Vijay K Nalla; Peter K Rogan; John A McGrath
Journal:  J Dermatol Sci       Date:  2005-07-27       Impact factor: 4.563

3.  Assessing predictions of the impact of variants on splicing in CAGI5.

Authors:  Stephen M Mount; Žiga Avsec; Liran Carmel; Rita Casadio; Muhammed Hasan Çelik; Ken Chen; Jun Cheng; Noa E Cohen; William G Fairbrother; Tzila Fenesh; Julien Gagneur; Valer Gotea; Tamar Holzer; Chiao-Feng Lin; Pier Luigi Martelli; Tatsuhiko Naito; Thi Yen Duong Nguyen; Castrense Savojardo; Ron Unger; Robert Wang; Yuedong Yang; Huiying Zhao
Journal:  Hum Mutat       Date:  2019-08-19       Impact factor: 4.878

4.  Variability of CYP2J2 expression in human fetal tissues.

Authors:  Andrea Gaedigk; Darren W Baker; Rheem A Totah; Roger Gaedigk; Robin E Pearce; Carrie A Vyhlidal; Darryl C Zeldin; J Steven Leeder
Journal:  J Pharmacol Exp Ther       Date:  2006-07-25       Impact factor: 4.030

5.  An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.

Authors:  Jamie D Kapplinger; David J Tester; Marielle Alders; Begoña Benito; Myriam Berthet; Josep Brugada; Pedro Brugada; Véronique Fressart; Alejandra Guerchicoff; Carole Harris-Kerr; Shiro Kamakura; Florence Kyndt; Tamara T Koopmann; Yoshihiro Miyamoto; Ryan Pfeiffer; Guido D Pollevick; Vincent Probst; Sven Zumhagen; Matteo Vatta; Jeffrey A Towbin; Wataru Shimizu; Eric Schulze-Bahr; Charles Antzelevitch; Benjamin A Salisbury; Pascale Guicheney; Arthur A M Wilde; Ramon Brugada; Jean-Jacques Schott; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2009-10-08       Impact factor: 6.343

6.  Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.

Authors:  Jamie D Kapplinger; David J Tester; Benjamin A Salisbury; Janet L Carr; Carole Harris-Kerr; Guido D Pollevick; Arthur A M Wilde; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2009-06-23       Impact factor: 6.343

7.  Identification of genetic variants of human cytochrome P450 2D6 with impaired mitochondrial targeting.

Authors:  Michelle Cook Sangar; Hindupur K Anandatheerthavarada; Martha V Martin; F Peter Guengerich; Narayan G Avadhani
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

8.  Tandem machine learning for the identification of genes regulated by transcription factors.

Authors:  Deendayal Dinakarpandian; Venetia Raheja; Saumil Mehta; Erin G Schuetz; Peter K Rogan
Journal:  BMC Bioinformatics       Date:  2005-08-22       Impact factor: 3.169

9.  CorreLogo: an online server for 3D sequence logos of RNA and DNA alignments.

Authors:  Eckart Bindewald; Thomas D Schneider; Bruce A Shapiro
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

10.  Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.

Authors:  Alice Matimba; Jurgen Del-Favero; Christine Van Broeckhoven; Collen Masimirembwa
Journal:  Hum Genomics       Date:  2009-01       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.